Back

Transcatheter Versus Surgical Aortic Valve Replacement in Medicare Beneficiaries with Bicuspid Aortic Stenosis (TREAT-BICUSPID): Statistical Analysis Plan

Patel, P. N.; Hulme, O. L.; Dong, H. N.; Song, Y.; Cohen, D. J.; Yeh, R. W.; Kolte, D.

2025-03-11 cardiovascular medicine
10.1101/2025.03.09.25323634 medRxiv
Show abstract

This document provides the full statistical analysis plan (SAP) for the TRanscatheter VErsus Surgical Aortic Valve ReplacemenT in Medicare Beneficiaries with Bicuspid Aortic Stenosis (TREAT-BICUSPID) study. TREAT-BICUSPID is a retrospective, population-based cohort study of Medicare beneficiaries with bicuspid aortic stenosis (AS) undergoing aortic valve replacement (AVR) from 2012 to 2022. The study was designed to evaluate trends in relative use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in this population over time, and compare 1-year outcomes of isolated TAVR and SAVR using an instrumental variable approach. The pre-specified SAP detailed in this document was posted on medRxiv prior to analysis of the primary outcomes.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.